Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Kintara Therapeutics, Inc.Financial_Report.xls
EX-31.1 - Kintara Therapeutics, Inc.ex31-1.txt
10-Q - Kintara Therapeutics, Inc.g6566.txt

                                                                      EXHIBIT 32

                                  CERTIFICATION
                           Pursuant to 18 U.S.C. 1350
                 (Section 906 of the Sarbanes-Oxley Act of 2002)

In connection with the Quarterly Report on Form 10-Q of Berry Only Inc. (the
"Company") for the period ended December 31, 2012, as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), Lisa Guise, as Chief
Executive Officer and Chief Financial Officer of the Company, hereby certifies,
pursuant to 18 U.S.C. ss.1350, as adopted pursuant to ss.906 of the
Sarbanes-Oxley Act of 2002, that:

     (1)  The Report fully complies with the requirements of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
          material respects, the financial condition and results of operations
          of the Company.


Date: January 18, 2013                 By: /s/ Lisa Guise
                                           -------------------------------------
                                           Lisa Guise, President,
                                           Chief Executive Officer and
                                           Chief Financial Officer Director

This certification accompanies each Report pursuant to ss. 906 of the
Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the
Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of ss.18
of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement required by Section 906 has been
provided to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request